Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205718) titled 'A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Takeda
Condition:
Advanced or Metastatic Solid Tumors
Intervention:
Drug: TAK-188
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: November 18, 2025
Target Sample Size: 223
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07205718
Published by HT Digital Co...